Pharma. Wants SAC-Linked Legal Fees Covered

Apr 1 2014 | 1:42pm ET

Pharmaceutical company Elan Corp. wants some of the $1.8 billion SAC Capital Advisors hopes to pay to settle insider-trading allegations.

Elan, whose shares former SAC trader Mathew Martoma was convicted of trading illegally, has asked to be declared a victim of the scheme under federal law. Such a designation would allow it to recoup $1.5 million in legal fees it incurred while cooperating with federal probes of SAC.

“Over the course of more than three years, Elan responded to numerous requests” from the Department of Justice, Federal Bureau of Investigation and Securities and Exchange Commission “for documents, electronic data and related materials,” Elan chief legal officer Gregory Bokar said.

U.S. District Judge Laura Taylor Swain is set to consider SAC’s guilty plea to insider-trading charges on April 10. As part of that deal, SAC has agreed to cease managing outside capital and to become a family office. The firm will change its name to Point72 Asset Management three days before the hearing.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Trump Attends 'Villains and Heroes' Costume Party Dressed As...Himself

Dec 5 2016 | 11:16pm ET

U.S. President-elect Donald Trump attended a "Villains and Heroes" costume party...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR